These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12042657)

  • 1. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation.
    van Rijen MM; Kuijf ML; Metselaar HJ; Tilanus HW; Bouma GJ; de Weger RA; Jonker M; Kwekkeboom J
    Transplantation; 2002 May; 73(10):1666-72. PubMed ID: 12042657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
    Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
    Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules.
    Van Rijen MM; Metselaar HJ; Hommes M; Ijzermans JN; Tilanus HW; Kwekkeboom J
    Immunology; 2003 May; 109(1):109-16. PubMed ID: 12709024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
    Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
    Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome.
    Bartlett A; McCall J; Ameratunga R; Munn S
    Clin Transplant; 2000 Dec; 14(6):520-8. PubMed ID: 11127303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients.
    Domenech N; Crespo-Leiro MG; Moscoso I; Paniagua MJ; Naya C; Muñiz J; Vazquez-Rodriguez JM; Castro-Beiras A
    Transplant Proc; 2003 Aug; 35(5):1994-5. PubMed ID: 12962873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.
    Smiley ST; Csizmadia V; Gao W; Turka LA; Hancock WW
    Transplantation; 2000 Aug; 70(3):415-9. PubMed ID: 10949181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
    Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD154 at the time of donor-specific blood transfusion does not improve kidney graft survival in rhesus monkeys.
    Ringers J; Ossevoort M; Haanstra K; Kroczek R; Volk D; Jonker M
    Transplant Proc; 2001; 33(1-2):524. PubMed ID: 11266938
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.
    Boleslawski E; Conti F; Sanquer S; Podevin P; Chouzenoux S; Batteux F; Houssin D; Weill B; Calmus Y
    Transplantation; 2004 Jun; 77(12):1815-20. PubMed ID: 15223897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
    Shoker A; George D; Yang H; Baltzan M
    Transplantation; 2000 Aug; 70(3):497-505. PubMed ID: 10949194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation.
    Pearl JP; Xu H; Leopardi F; Preston E; Kirk AD
    Transplantation; 2007 May; 83(9):1219-25. PubMed ID: 17496539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.